Management of Anemia: ESAs Reconsidered
This information was originally presented on September 15, 2012, at the NCCN 7th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Outline independent indications and contraindications of ESA
- Summarize mixed data on ESA risks in specific clinical settings
- Describe the role of iron supplementation in anemia management
Jeffrey Crawford, MD
Duke Cancer Institute
- 0.50 Participation
- 0.60 Nurse
- 0.50 Pharmacist
- 0.50 Physician